BioOptics Stock Watch
Markets
Stocks
Funds
Sectors
Tools
Current Price
Components
Dashboard
Latest News
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
BioOptics Stock Watch (CIX: BOSW)
4,445.43   -25.48 (-0.57%)
Streaming Delayed Price  /  Updated: 1:23 PM EDT, Aug 17, 2017  /  Add to My Watchlist      
View: Quote Components News
Index Value
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Price 4445.43
Volume 0
Open 4455.66
Prev. Close 4470.91
Change
-25.48
% Change
-0.57%
Today's Range 4431.94 - 4525.96
52wk Range 3977.76 - 5872.44
Performance
YTD
-395.24 (-8.16%)
1 Month
+21.35 (0.48%)
3 Month
+200.12 (4.71%)
6 Month
-619.14 (-12.22%)
1 Year
-677.22 (-13.22%)
Top News
More News
Zecotek Receives LFS Scintillation Crystal Order for NeuroPET Brain Scanning Device
from Marketwired News Releases
Zecotek Receives LFS Scintillation Crystal Order for NeuroPET Brain Scanning Device
from Marketwired
More News
More News
Cocrystal Announces Positive Data from the Successful Completion of Phase 1a/1b Trial of the Non-Nucleoside Polymerase Inhibitor CC-31244 for the Treatment of Chronic Hepatitis C Infection
from Marketwired News Releases
Stocks Generating Improved Relative Strength: Haemonetics
A Relative Strength Rating upgrade for Haemonetics shows improving technical performance. Will it continue? Read More
from Investor's Business Daily
Xenetic Biosciences Reports 2017 Second Quarter Financial Results and Provides Business Update
Xenetic Biosciences, Inc. (NASDAQ: XBIO) (“Xenetic” or the “Company”), a clinical-stage biopharmaceutical company focused on the discovery, research and development of next-generation biologic drugs... Read More
from Business Wire News Releases
Haemonetics Sees Relative Strength Rating Climb To 72
A Relative Strength Rating upgrade for Haemonetics shows improving technical performance. Will it continue? Read More
from Investor's Business Daily
Varian Medical Systems Shows Market Leadership With Jump To 81 RS Rating
Varian Medical Systems sees its Relative Strength Rating hit the 80-plus level. Read More
from Investor's Business Daily
BRIEF-Opko Health CEO Phillip Frost? buys 40,000 shares of co's common stock on Aug 16
* Opko Health CEO Phillip Frost? reports purchase of 40,000 shares of co's common stock on Aug 16 - SEC filing Source text: (http://bit.ly/2i8raa9) Further company coverage: Read More
from Reuters: Company News
Xenetic Biosciences Announces Appointment of Three Directors to the Board
Xenetic Biosciences, Inc. (NASDAQ: XBIO) (“Xenetic” or the “Company”), a clinical-stage biopharmaceutical company focused on the discovery, research and development of next-generation biologic drugs... Read More
from Business Wire News Releases
Stocks To Watch: Idexx Laboratories Sees Relative Strength Rating Jump To 83
Idexx Laboratories sees its Relative Strength Rating enter the 80-plus level. Read More
from Investor's Business Daily
Varian Medical Systems Sees RS Rating Improve To 74
A Relative Strength Rating upgrade for Varian Medical Systems shows improving technical performance. Will it continue? Read More
from Investor's Business Daily
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS